20.01
Sanara Medtech Inc stock is traded at $20.01, with a volume of 87,379.
It is up +8.10% in the last 24 hours and up +2.72% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
See More
Previous Close:
$18.51
Open:
$18.78
24h Volume:
87,379
Relative Volume:
1.34
Market Cap:
$183.43M
Revenue:
$103.14M
Net Income/Loss:
$-5.82M
P/E Ratio:
-4.5973
EPS:
-4.3526
Net Cash Flow:
$2.14M
1W Performance:
+17.71%
1M Performance:
+2.72%
6M Performance:
-33.08%
1Y Performance:
-31.89%
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SMTI
Sanara Medtech Inc
|
20.01 | 169.68M | 103.14M | -5.82M | 2.14M | -4.3526 |
|
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
SMTI Initiates Coverage On Lake Street -- Rating Set to Buy - GuruFocus
Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach - MSN
Baird entities report 21,075 shares in Sanara MedTech (SMTI) Schedule 13G/A - Stock Titan
Sanara MedTech to Report Q1 2026 Earnings on May 12 - National Today
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 - The Manila Times
Sanara MedTech sets May 12 webcast for first-quarter 2026 results - Stock Titan
Sanara MedTech Faces Securities Fraud Probe After Tissue Health Plus Shutdown - National Today
Aug Analyst Calls: Does Sanara MedTech Inc have pricing power2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
EV Market: Can Sanara MedTech Inc grow without external funding2026 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn
Inflation Data: Whats next for Sanara MedTech Inc stock2026 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Sanara MedTech Investigated for Potential Securities Fraud - National Today
Sanara MedTech, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Volume Recap: How does Sanara MedTech Inc correlate with Nasdaq2026 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (SMTI) Edition - Stock Traders Daily
Chart Watch: Is Sanara MedTech Inc stock a top performer YTDSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
Tech Rally: Is Sanara MedTech Inc vulnerable to short sellers2026 Stock Rankings & Consistent Growth Equity Picks - baoquankhu1.vn
Q1 EPS Estimates for Sanara MedTech Lowered by HC Wainwright - Defense World
SMTI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Momentum Shift: Can Sanara MedTech Inc grow without external fundingRecession Risk & Smart Money Movement Alerts - baoquankhu1.vn
H.C. Wainwright reiterates Sanara MedTech stock rating at buy By Investing.com - Investing.com Canada
Sanara MedTech (NASDAQ:SMTI) Lowered to Hold Rating by Wall Street Zen - Defense World
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI) - Defense World
Q4 EPS Estimates for Sanara MedTech Decreased by Analyst - MarketBeat
Recap Report: Is Sanara MedTech Inc undervalued by DCF analysis2026 Top Decliners & Stepwise Swing Trade Plans - baoquankhu1.vn
Aug Chart Watch: Is Sanara MedTech Inc showing insider buying2026 Technicals & Reliable Entry Point Alerts - baoquankhu1.vn
(SMTI) Volatility Zones as Tactical Triggers - Stock Traders Daily
Sanara MedTech Q4 2025 Earnings Call Transcript - MarketBeat
Sanara MedTech Earnings Call Signals Growth Momentum - The Globe and Mail
Sanara MedTech (NASDAQ:SMTI) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Sanara MedTech shares rise more than 3% despite fourth-quarter earnings miss - MSN
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2025 Earnings Call Transcript - Insider Monkey
Retail Trends: Can Sanara MedTech Inc maintain sales growth2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Sanara MedTech Hits 52-Week Low of $17.54 Amidst Market Struggles - Markets Mojo
Sanara MedTech Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Sanara MedTech Reports Strong 2025 Financial Results With 19% Revenue Growth, Reaffirms 2026 Guidance - Minichart
Sanara MedTech (SMTI) to Release Quarterly Earnings on Wednesday - MarketBeat
Sanara MedTech Inc. 2025 Business Overview: Surgical Product Focus, Innovation Strategy, and Regulatory Compliance - Minichart
Sanara MedTech Inc. (SMTI) Q4 earnings miss estimates - MSN
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - ca.investing.com
Sanara MedTech (NASDAQ: SMTI) ends THP unit, doubles down on surgery - Stock Titan
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Reco - GuruFocus
Sanara MedTech stock rises over 3% despite fourth quarter miss By Investing.com - Investing.com India
Targets Report: Can Sanara MedTech Inc deliver consistent dividends2026 Market Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Sanara MedTech Inc. (SMTI) Q4 and Full Year 2025 Earnings: Revenue Hits $103.1 Million With 19% Growth - Bayelsa Watch
Earnings Call Summary | Sanara MedTech(SMTI.US) Q4 2025 Earnings Conference - 富途牛牛
Sanara Medtech earnings missed by $0.52, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Sanara MedTech Q4 2025 misses EPS forecast, stock drops - in.investing.com
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap - AlphaStreet
Sanara MedTech Q4 Earnings Call Highlights - Yahoo Finance
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates - Yahoo Finance
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):